Significant Ownership of GILEAD SCIENCES, INC.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for GILEAD SCIENCES, INC. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Andrew D. Dickinson - Andrew D. Dickinson, Chief Financial Officer
- Manager location
- Foster City, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow GILEAD SCIENCES, INC. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from GILEAD SCIENCES, INC.
Significant Ownership of GILEAD SCIENCES, INC.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ACLX | Arcellx, Inc. | Common Stock, par value $0.001 | 100% | $11,482 | -$771,671,118 | 100 | -100% | GILEAD SCIENCES, INC. | 28 Apr 2026 |
| GLPG | Galapagos NV | Ordinary Shares, no par value | 30% | $555,786,955 | 20,981,010 | Gilead Sciences, Inc. | 07 Jan 2025 | ||
| RCUS | Arcus Biosciences, Inc. | Common Stock, par value $0.0001 | 26% | $427,376,736 | 31,424,760 | 0% | GILEAD SCIENCES, INC. | 03 Nov 2025 | |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | Common Stock, par value $0.001 | 25% | 4,977,089 | +10% | GILEAD SCIENCES, INC. | 22 May 2026 | ||
| XLO | Xilio Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 20% | $9,581,667 | +$2,576,464 | 14,517,678 | +37% | GILEAD SCIENCES, INC. | 31 Dec 2025 |
| KLRS | Kalaris Therapeutics, Inc. | Common Stock, $0.0001 per value | 3.9% | $4,715,740 | 723,273 | GILEAD SCIENCES, INC. | 18 Mar 2025 | ||
| IKNA | Ikena Oncology, Inc. | Common Stock | 3.6% | $1,612,591 | 1,521,312 | GILEAD SCIENCES INC | 31 Dec 2024 | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | Common Stock, par value $0.001 per share | 0% | $0 | 0 | GILEAD SCIENCES, INC. | 31 Dec 2025 |
Schedules 13D/G Reported by GILEAD SCIENCES, INC.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.